Scholars@Duke publication: Prospective validation of a risk model for first cycle neutropenic complications in patients receiving cancer chemotherapy.

Prospective validation of a risk model for first cycle neutropenic complications in patients receiving cancer chemotherapy.

Publication , Conference

Lyman, GH; Kuderer, NM; Crawford, J; Wolff, DA; Culakova, E; Poniewierski, MS; Dale, DC

Published in: JOURNAL OF CLINICAL ONCOLOGY

2006

JOURNAL OF CLINICAL ONCOLOGY

0732-183X

2006

483S / 483S

APA

Chicago

ICMJE

MLA

NLM

Lyman, G. H., Kuderer, N. M., Crawford, J., Wolff, D. A., Culakova, E., Poniewierski, M. S., & Dale, D. C. (2006). Prospective validation of a risk model for first cycle neutropenic complications in patients receiving cancer chemotherapy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 24, pp. 483S-483S).

Lyman, G. H., N. M. Kuderer, J. Crawford, D. A. Wolff, E. Culakova, M. S. Poniewierski, and D. C. Dale. “Prospective validation of a risk model for first cycle neutropenic complications in patients receiving cancer chemotherapy.” In JOURNAL OF CLINICAL ONCOLOGY, 24:483S-483S, 2006.

Lyman GH, Kuderer NM, Crawford J, Wolff DA, Culakova E, Poniewierski MS, et al. Prospective validation of a risk model for first cycle neutropenic complications in patients receiving cancer chemotherapy. In: JOURNAL OF CLINICAL ONCOLOGY. 2006. p. 483S-483S.

Lyman GH, Kuderer NM, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC. Prospective validation of a risk model for first cycle neutropenic complications in patients receiving cancer chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2006. p. 483S-483S.

JOURNAL OF CLINICAL ONCOLOGY

0732-183X

2006

483S / 483S